Skip to Main Content
Contribute Try STAT+ Today

The large sums of money spent on advertising prescription drugs directly to consumers may have contributed to increased use by Medicare beneficiaries and driven up spending by the federal health care program, according to a new report by the Government Accountability Office.

The analysis found Medicare Parts B and D, as well as beneficiaries, spent $560 billion on medicines from 2016 through 2018. More than half of that spending — $324 billion — went to purchasing drugs that were advertised directly to consumers. Of the 553 advertised drugs, the GAO found that Medicare Parts B and D purchased 104 and 463 drugs, respectively.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment